38 related articles for article (PubMed ID: 26738330)
21. MicroRNA in prostate cancer: Practical aspects.
Patil PA; Magi-Galluzzi C
Histol Histopathol; 2015 Dec; 30(12):1379-96. PubMed ID: 26186079
[TBL] [Abstract][Full Text] [Related]
22. MiRNA 34a: a therapeutic target for castration-resistant prostate cancer.
Chalanqui MJ; O'Doherty M; Dunne NJ; McCarthy HO
Expert Opin Ther Targets; 2016 Sep; 20(9):1075-85. PubMed ID: 26942553
[TBL] [Abstract][Full Text] [Related]
23. Non-coding RNAs in pancreatic cancer: challenges and opportunities for clinical application.
Taucher V; Mangge H; Haybaeck J
Cell Oncol (Dordr); 2016 Aug; 39(4):295-318. PubMed ID: 27060060
[TBL] [Abstract][Full Text] [Related]
24. Current Insights into Long Non-Coding RNAs (LncRNAs) in Prostate Cancer.
Smolle MA; Bauernhofer T; Pummer K; Calin GA; Pichler M
Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28241429
[TBL] [Abstract][Full Text] [Related]
25. Functional significance of aberrantly expressed microRNAs in prostate cancer.
Goto Y; Kurozumi A; Enokida H; Ichikawa T; Seki N
Int J Urol; 2015 Mar; 22(3):242-52. PubMed ID: 25599923
[TBL] [Abstract][Full Text] [Related]
26. [Current status of castration resistant prostate cancer basic research].
Sakamoto S; Ichikawa T
Nihon Rinsho; 2014 Dec; 72(12):2097-102. PubMed ID: 25518340
[TBL] [Abstract][Full Text] [Related]
27. Emerging roles of miR-210 and other non-coding RNAs in the hypoxic response.
Huang X; Zuo J
Acta Biochim Biophys Sin (Shanghai); 2014 Mar; 46(3):220-32. PubMed ID: 24395300
[TBL] [Abstract][Full Text] [Related]
28. Non-coding RNAs: Emerging roles in the characterization of immune microenvironment and immunotherapy of prostate cancer.
Yang F; Li J; Ge Q; Zhang Y; Zhang M; Zhou J; Wang H; Du J; Gao S; Liang C; Meng J
Biochem Pharmacol; 2023 Aug; 214():115669. PubMed ID: 37364622
[TBL] [Abstract][Full Text] [Related]
29. Non-coding RNAs in cardiac fibrosis: Emerging biomarkers and therapeutic targets.
Chen Z; Li C; Lin K; Cai H; Ruan W; Han J; Rao L
Cardiol J; 2018; 25(6):732-741. PubMed ID: 29240957
[TBL] [Abstract][Full Text] [Related]
30. Large non-coding RNAs: missing links in cancer?
Huarte M; Rinn JL
Hum Mol Genet; 2010 Oct; 19(R2):R152-61. PubMed ID: 20729297
[TBL] [Abstract][Full Text] [Related]
31. Non-coding RNAs in metabolic reprogramming of bone and soft tissue sarcoma: Fundamental mechanism and clinical implication.
Chen HH; Hao PH; Zhang FY; Zhang TN
Biomed Pharmacother; 2023 Apr; 160():114346. PubMed ID: 36738505
[TBL] [Abstract][Full Text] [Related]
32. [Non-coding RNAs in castration-resistant prostate cancer].
Xie GP; Jiang R
Zhonghua Nan Ke Xue; 2015 Nov; 21(11):1014-9. PubMed ID: 26738330
[TBL] [Abstract][Full Text] [Related]
33. Non-Coding RNAs in Castration-Resistant Prostate Cancer: Regulation of Androgen Receptor Signaling and Cancer Metabolism.
Shih JW; Wang LY; Hung CL; Kung HJ; Hsieh CL
Int J Mol Sci; 2015 Dec; 16(12):28943-78. PubMed ID: 26690121
[TBL] [Abstract][Full Text] [Related]
34. Molecular Mechanisms of Noncoding RNA in the Occurrence of Castration-Resistant Prostate Cancer.
Lin Y; Tan H; Yu G; Zhan M; Xu B
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674820
[TBL] [Abstract][Full Text] [Related]
35. The Crosstalk of Long Non-Coding RNA and MicroRNA in Castration-Resistant and Neuroendocrine Prostate Cancer: Their Interaction and Clinical Importance.
Hu CY; Wu KY; Lin TY; Chen CC
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008817
[TBL] [Abstract][Full Text] [Related]
36. Microdissecting the role of microRNAs in the pathogenesis of prostate cancer.
Ayub SG; Kaul D; Ayub T
Cancer Genet; 2015 Jun; 208(6):289-302. PubMed ID: 26004033
[TBL] [Abstract][Full Text] [Related]
37. The roles of microRNAs in the progression of castration-resistant prostate cancer.
Kojima S; Goto Y; Naya Y
J Hum Genet; 2017 Jan; 62(1):25-31. PubMed ID: 27278789
[TBL] [Abstract][Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
